ES472384A1 - Un procedimiento para la preparacion de derivados de amino- piridina - Google Patents

Un procedimiento para la preparacion de derivados de amino- piridina

Info

Publication number
ES472384A1
ES472384A1 ES472384A ES472384A ES472384A1 ES 472384 A1 ES472384 A1 ES 472384A1 ES 472384 A ES472384 A ES 472384A ES 472384 A ES472384 A ES 472384A ES 472384 A1 ES472384 A1 ES 472384A1
Authority
ES
Spain
Prior art keywords
substituted amino
pyridine derivatives
alkyl
hydrogen
processes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES472384A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beecham Group PLC
Original Assignee
Beecham Group PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group PLC filed Critical Beecham Group PLC
Publication of ES472384A1 publication Critical patent/ES472384A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • C07D213/80—Acids; Esters in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/84—Nitriles
    • C07D213/85—Nitriles in position 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Un procedimiento para la preparación de derivados de aminopiridina de fórmula **(Fórmula)** donde R3 es hidrógeno o un grupo ácido carboxílico o una sal o éster farmacéuticamente aceptable de un grupo ácido carboxílico; un grupo alquilo opcionalmente sustituido con uno o más grupos hidroxilo; o un grupo nitrilo, formilo, tetrazolilo o alquil (C1-6)carbonilo; R2 es hidrógeno o alquilo C1-6; R4 y R5 son hidrógeno, alquilo C1-6 ó halógeno; Z representa hidrógeno, fenilo o alquilo C1-6, opcionalmente sustituido con fenilo; Alq representa un grupo alquileno de cadena lineal o ramificada conteniendo hasta 12 átomos de carbono; x es 0 ó 1 y R1 representa fenilo o naftilo, opcionalmente sustituido con hasta tres grupos seleccionados entre alquilo C1-6, fenilo, halógeno, alcoxi C1-6, amino, nitro, hidroxi, alquilamido C1-6, alquil(C1-6)carboniloxi, carboxi, alcoxi(C1-6)carbonilo, halolaquilo C1-6 y oxoalquilo.
ES472384A 1977-08-06 1978-08-04 Un procedimiento para la preparacion de derivados de amino- piridina Expired ES472384A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB3305577 1977-08-06
GB1940678 1978-05-13

Publications (1)

Publication Number Publication Date
ES472384A1 true ES472384A1 (es) 1979-10-01

Family

ID=26254035

Family Applications (4)

Application Number Title Priority Date Filing Date
ES472384A Expired ES472384A1 (es) 1977-08-06 1978-08-04 Un procedimiento para la preparacion de derivados de amino- piridina
ES479931A Expired ES479931A1 (es) 1977-08-06 1979-04-25 Un procedimiento para la preparacion de derivados de amino- piridina.
ES479933A Expired ES479933A1 (es) 1977-08-06 1979-04-25 Un procedimiento para la preparacion de derivados de amino- piridina.
ES479932A Expired ES479932A1 (es) 1977-08-06 1979-04-25 Un procedimiento para la preparacion de derivados de amino- piridina.

Family Applications After (3)

Application Number Title Priority Date Filing Date
ES479931A Expired ES479931A1 (es) 1977-08-06 1979-04-25 Un procedimiento para la preparacion de derivados de amino- piridina.
ES479933A Expired ES479933A1 (es) 1977-08-06 1979-04-25 Un procedimiento para la preparacion de derivados de amino- piridina.
ES479932A Expired ES479932A1 (es) 1977-08-06 1979-04-25 Un procedimiento para la preparacion de derivados de amino- piridina.

Country Status (7)

Country Link
EP (1) EP0000816A1 (es)
JP (1) JPS5441881A (es)
AU (1) AU3862078A (es)
DK (1) DK346278A (es)
ES (4) ES472384A1 (es)
IL (1) IL55242A0 (es)
IT (1) IT1106623B (es)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1160229A (en) * 1979-03-13 1984-01-10 Pieter T. Haken Pyridyliminomethylbenzene derivatives
EP0018134B1 (en) * 1979-04-21 1984-03-14 Beecham Group Plc Dihydropyridine derivatives, processes for their preparation and pharmaceutical compositions containing them
JPS5938653B2 (ja) * 1980-05-30 1984-09-18 日本ビクター株式会社 電極付き針の製作法
JPS5798143A (en) * 1980-12-05 1982-06-18 Victor Co Of Japan Ltd Base body of detection type for variation in electrostatic capacity value
DE3124673A1 (de) * 1981-06-24 1983-01-13 Bayer Ag, 5090 Leverkusen Subsituierte 2-amino-pyridinderivate, verfahren zu ihrer herstellung, ihre verwendung in arzneimitteln, sowie deren herstellung
US4552960A (en) * 1983-06-20 1985-11-12 Eli Lilly And Company Fungicidal amines
US4774251A (en) * 1984-06-18 1988-09-27 Eli Lilly And Company Method of inhibiting aromatase
US4855308A (en) * 1987-12-04 1989-08-08 Warner-Lambert Company Method of treating senile cognitive decline with N'-substituted aminopyridine adrenergic agents
US4931457B1 (en) * 1989-06-28 1993-11-16 Hoechst-Roussel Pharmaceuticals Incorporated Naphthylamino-and naphthyloxy-pyridineamin compounds useful as topical antiinflammatory agents for the treatment of skin disorders
AU630877B2 (en) * 1989-07-28 1992-11-12 Ah N. Fah Improved automatic plant watering and feeding system
FR2668770A1 (fr) * 1990-11-07 1992-05-07 Nyco Sa Esters d'acides amines heterocycliques et leurs derives, et leur application comme additifs anti-oxydants pour les huiles de graissage a temperature elevee.
GB9514160D0 (en) * 1994-07-25 1995-09-13 Zeneca Ltd Aromatic compounds
GB9420557D0 (en) * 1994-10-12 1994-11-30 Zeneca Ltd Aromatic compounds
TW434240B (en) * 1995-06-20 2001-05-16 Zeneca Ltd Aromatic compounds, preparation thereof and pharmaceutical composition comprising same
TW502026B (en) 1995-06-20 2002-09-11 Zeneca Ltd Aromatic compounds useful as antagonists of e-type prostaglandins, processes for the preparation thereof, pharmaceutical compositions comprising the compounds, and intermediates
EP0752421B1 (en) * 1995-07-07 2005-10-12 AstraZeneca AB Ortho-substituted aromatic compounds, containing three (het)aryl moieties, their preparation and their use as prostaglandin E2-(PGE2)-antagonists
JP4533534B2 (ja) 1998-06-19 2010-09-01 ノバルティス バクシンズ アンド ダイアグノスティックス，インコーポレーテッド グリコーゲンシンターゼキナーゼ３のインヒビター
DE19845406C2 (de) * 1998-10-02 2001-10-18 Aventis Pharma Gmbh Substituierte 1,3-Diaryl-2-pyridin-2-yl-3-(pyridin-2-ylamino)- propanolderivate, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung
WO2000069810A1 (en) * 1999-05-17 2000-11-23 Novo Nordisk A/S Glucagon antagonists/inverse agonists
US6503949B1 (en) 1999-05-17 2003-01-07 Noro Nordisk A/S Glucagon antagonists/inverse agonists
RU2168501C1 (ru) * 1999-10-19 2001-06-10 Институт нефтехимии и катализа АН РБ и УНЦ РАН 2-(N-МЕТИЛ-α-ФЕНИЛ(Н-ПРОПИЛ)АМИН)-3-МЕТИЛПИРИДИН В КАЧЕСТВЕ ИНГИБИТОРА КИСЛОТНОЙ КОРРОЗИИ СТАЛИ
RU2168500C1 (ru) * 1999-10-20 2001-06-10 Институт нефтехимии и катализа АН РБ и УНЦ РАН 2-(N-МЕТИЛ-α-ФЕНИЛ(Н-БУТИЛ)АМИН)-4-МЕТИЛПИРИДИН В КАЧЕСТВЕ ИНГИБИТОРА КИСЛОТНОЙ КОРРОЗИИ СТАЛИ
CN1635890A (zh) * 2000-08-08 2005-07-06 奥索-麦克尼尔药品公司 神经保护性2－吡啶胺组合物和相关方法
DE602006006985D1 (de) * 2005-03-28 2009-07-09 Boehringer Ingelheim Pharma Pyridinderivate als pkc-theta-hemmer
KR101171480B1 (ko) 2007-07-02 2012-08-07 에프. 호프만-라 로슈 아게 Ｃｃｒ-2 수용체 길항제로서의 이미다졸 유도체

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2784138A (en) * 1953-03-07 1957-03-05 Bayer Ag Fungicidal compositions of nu-arylhydroxyarylmethylamines
DE1119274B (de) * 1954-03-19 1961-12-14 Raschig Gmbh Dr F Verfahren zur Herstellung von 2-Amino-4-alkyl-pyridinen
NL132603C (es) * 1964-08-29
DE1670522C3 (de) * 1966-05-12 1978-08-31 Deutsche Gold- Und Silber-Scheideanstalt Vormals Roessler, 6000 Frankfurt Neue Benzylaminopyridine
NL6707290A (es) * 1966-05-28 1967-11-29
US3450707A (en) * 1966-12-13 1969-06-17 Sterling Drug Inc Certain 2-anilino-pyridine derivatives
US3535328A (en) * 1967-09-01 1970-10-20 Exxon Research Engineering Co Certain substituted aminothioethoxy pyridines
FR2050940A5 (es) * 1969-06-30 1971-04-02 Rhone Poulenc Sa
DE2141418A1 (de) * 1970-08-18 1972-03-09 Roemmers S.A. Industrial Comercial Y Financiera, Buenos Aires Anilinderivate der Nikotinsäure und ihre Salze
FR2155922A2 (en) * 1971-10-15 1973-05-25 Aries Robert Organophosphorus pesticides - stabilized by amino- or aminoalkyl-pyridines
DE2230392A1 (de) * 1972-06-22 1974-01-31 Cassella Farbwerke Mainkur Ag Substituierte pyridinverbindungen und verfahren zu ihrer herstellung
GB1405308A (en) * 1972-12-13 1975-09-10 Basf Ag Amino-pytidines as coupling components for azo dyes
FR2288798A1 (fr) * 1974-10-24 1976-05-21 Popescu Francine Bain et procede de zingage electrolytique brillant
DE2605467A1 (de) * 1976-02-12 1977-08-18 Basf Ag Pyridinverbindungen

Also Published As

Publication number Publication date
ES479932A1 (es) 1979-12-01
EP0000816A1 (en) 1979-02-21
ES479931A1 (es) 1979-12-01
IT7850601A0 (it) 1978-08-04
IT1106623B (it) 1985-11-11
JPS5441881A (en) 1979-04-03
ES479933A1 (es) 1979-12-01
IL55242A0 (en) 1978-09-29
DK346278A (da) 1979-02-07
AU3862078A (en) 1980-02-07

Similar Documents

Publication Publication Date Title
ES479933A1 (es) Un procedimiento para la preparacion de derivados de amino- piridina.
GR3005315T3 (es)
ES481729A1 (es) Procedimiento para la preparacion de derivados de 1,2-dihi- droquinolein-2-onas.
ES8307806A1 (es) "procedimiento para la preparacion de 1,2-a piridinas y pirazinas".
IL68075A0 (en) Pyridine and pyrane derivatives,their preparation and pharmaceutical compositions containing them
ES8401468A1 (es) Un procedimiento para preparar derivados de nicotinamida.
HUP9902340A2 (hu) Kondenzált piridinek és pirimidinek aril-amino-származékai, eljárás előállításukra, valamint e vegyületeket tartalmazó gyógyászati készítmények, továbbá e vegyületek alkalmazása
MY101359A (en) 7-acylamino-3-vinylcephalosporanic acid derivatives, processes for their preparation, pharmaceutical compositions containing them, their starting compounds and their preparation
MY100574A (en) 5-substituted-2-cyclopropyl-6, 8-difluoroquinoline derivatives and processes for preparation thereof
ES8503343A1 (es) "un procedimiento para preparar derivados de carboximida"
MY103602A (en) Heterocyclic compounds
ES8101550A1 (es) Un procedimiento para la preparacion de nuevos derivados de 2-pirrolidin-metanol.
MY101142A (en) 1, 4-dihydropyridine derivative, process for production thereof, and pharmaceutical use thereof.
IL85768A0 (en) Benzoxazine derivatives,their preparation and pharmaceutical compositions containing them
AU7414691A (en) New 3-aminochroman derivatives, process for preparing these and pharmaceutical compositions containing them
ES8303393A1 (es) Un procedimiento para preparar derivados del acido ascorbico.
DE3375917D1 (en) Thiomethylpyridine derivatives, process for their preparation and medicaments containing them
ES8303397A1 (es) Un procedimiento para la preparacion de nuevos derivados de quinoleinetanol o quinoleinpropanol utiles como medicamentos
JPS5430183A (en) 3,4-dihydrocarbostyril derivative
ES468127A1 (es) Un procedimiento para la preparacion de nuevos derivados de pirido (2,1-b) quinazolina
IL50874A (en) S-(6-(n'-methylthioureido)alkyl)and s(5-(n'-cyano-n"-methylguanidino)alkyl)isothiourea derivatives,process for their preparation and pharmaceutical compositions containing them
ES8200347A1 (es) Procedimiento de preparacion de derivados de la piridina.
HUT39158A (en) Process for preparing carbacyclines and pharmaceutical compositions containing such compounds
ES461262A1 (es) Procedimiento para la preparacion de nuevas amidinas.
ATE25661T1 (de) Aphidicolanderivate, ihre herstellung und sie enthaltende pharmazeutische zusammensetzungen.